8,9 Spurred by recent approvals, the obesity market is expected to be worth over $100 billion by the end of the decade, up from $2.8 billion in 2022
Steven Gundry
The wave of upcoming medications could also help people who havent responded well to existing GLP-1 drugs
Six months of compounded semaglutide injections: $179 + (5 x $299) = $1,674 Twelve months of compounded semaglutide injections: $179 + (11 x $299) = $3,468 Six months of compounded tirzepatide injections: $279 + (5 x $399) = $2,274 Twelve months of compounded tirzepatide injections: $279 + (11 x $399) = $4,668 These figures make MEDVi one of the more affordable options for compounded GLP-1 medications, particularly compared to brand-name pricing
For more information, see our guide on GLP-1 use and pregnancy
Lin SK, Tsai SM, Huang JC, Lee SC, Wu SH, Wu SH, et al